Sponsored Links

Rituximab Maintenance Significantly Improves Progression-Free Survival In Patients With Follicular Lymphoma PDF Print E-mail
Medical News - Lymphoma and Leukemia
Patients with follicular lymphoma, a slow-growing common type of non-Hodgkin's lymphoma, who are given 2 years of rituximab-maintenance therapy after immunochemotherapy, have significantly better progression-free survival (PFS) and higher response rates compared with patients who do not receive this intervention...

Read more: Lymphoma / Leukemia / Myeloma News From Medical News Today